Yu Y - Search Results

1

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.

Planchard D, Jänne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, Kobayashi K; FLAURA2 Investigators. Planchard D, et al. Among authors: yu y. N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.

2

Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency.

Liu J, Liu C, Tang J, Chen Q, Yu Y, Dong Y, Hao J, Wu W. Liu J, et al. Among authors: yu y. J Nanobiotechnology. 2024 Jan 10;22(1):25. doi: 10.1186/s12951-023-02196-4. J Nanobiotechnology. 2024. PMID: 38195456 Free PMC article.

3

AntDAS-GCMS: A New Comprehensive Data Analysis Platform for GC-MS-Based Untargeted Metabolomics with the Advantage of Addressing the Time Shift Problem.

Ma GM, Wang JN, Wang XC, Ma FL, Wang WX, Li SF, Liu PP, Lv Y, Yu YJ, Fu HY, She Y. Ma GM, et al. Among authors: yu yj. Anal Chem. 2024 May 28. doi: 10.1021/acs.analchem.4c00100. Online ahead of print. Anal Chem. 2024. PMID: 38805056

4

Pregnant outcomes of patients with positive anticentromere antibodies receiving in vitro fertilization-embryo transfer.

Tian Y, Zhou Y, Fan Y, Chen S, Guo X, Yu Y, Wu X, Xu W, Shu J. Tian Y, et al. Among authors: yu y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 27:1-9. doi: 10.3724/zdxbyxb-2023-0559. Online ahead of print. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38803288 Chinese, English.

5

[Advances in clinical management of neonatal sepsis].

Yu YQ, Chen PY. Yu YQ, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2024 May 15;26(5):518-522. doi: 10.7499/j.issn.1008-8830.2309145. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38802914 Review. Chinese.

6

Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis.

Ma Z, Sun Y, Yu Y, Xiao W, Xiao Z, Zhong T, Xiang X, Li Z. Ma Z, et al. Among authors: yu y. Cell Commun Signal. 2024 May 27;22(1):295. doi: 10.1186/s12964-024-01669-9. Cell Commun Signal. 2024. PMID: 38802814

7

A study on the application of radiomics based on cardiac MR non-enhanced cine sequence in the early diagnosis of hypertensive heart disease.

Ma ZP, Wang SW, Xue LY, Zhang XD, Zheng W, Zhao YX, Yuan SR, Li GY, Yu YN, Wang JN, Zhang TL. Ma ZP, et al. Among authors: yu yn. BMC Med Imaging. 2024 May 27;24(1):124. doi: 10.1186/s12880-024-01301-9. BMC Med Imaging. 2024. PMID: 38802736

8

CD40L-Activated DC Promotes Th17 Differentiation and Inhibits Th2 Differentiation in Sepsis-Induced Lung Injury via cGAS-STING Signaling.

Yu W, Yang M, Lv B, Yu Y, Zhu W. Yu W, et al. Among authors: yu y. Biochem Genet. 2024 May 27. doi: 10.1007/s10528-024-10835-0. Online ahead of print. Biochem Genet. 2024. PMID: 38802692

9

Authors' response to letter to editor.

Shin E, Yu Y, Bies RR, Ramanathan M. Shin E, et al. Among authors: yu y. J Pharmacokinet Pharmacodyn. 2024 May 27. doi: 10.1007/s10928-024-09927-6. Online ahead of print. J Pharmacokinet Pharmacodyn. 2024. PMID: 38802683

10

Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation.

Han Q, Li Y, Yu Y, Yuan H, Wang Z, Guo Y, Shi J, Xue Y, Liu X. Han Q, et al. Among authors: yu y. Sci Rep. 2024 May 27;14(1):12119. doi: 10.1038/s41598-024-63088-7. Sci Rep. 2024. PMID: 38802644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,212 results

Search Page